Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?

J Diabetes Investig. 2021 Apr;12(4):479-481. doi: 10.1111/jdi.13484. Epub 2021 Jan 18.

Abstract

Publication types

  • Comment

MeSH terms

  • Acidosis*
  • COVID-19*
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Incidence
  • Metformin* / therapeutic use
  • SARS-CoV-2

Substances

  • Hypoglycemic Agents
  • Metformin